Bacterial-induced or passively administered interferon gamma conditions the lung for early control of SARS-CoV-2.

Autor: Hilligan KL; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA. khilligan@malaghan.org.nz.; Malaghan Institute of Medical Research, Wellington, 6012, New Zealand. khilligan@malaghan.org.nz., Namasivayam S; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Clancy CS; Rocky Mountain Veterinary Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT, 59840, USA., Baker PJ; Inflammation and Innate Immunity Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Old SI; Malaghan Institute of Medical Research, Wellington, 6012, New Zealand., Peluf V; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.; Immunoparasitology Unit, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Amaral EP; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Oland SD; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., O'Mard D; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Laux J; Flow Cytometry Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Cohen M; Flow Cytometry Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Garza NL; SARS-CoV2- Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Lafont BAP; SARS-CoV2- Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Johnson RF; SARS-CoV2- Virology Core, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Feng CG; Immunology and Host Defense Group, School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, 2006, Australia.; Centenary Institute, The University of Sydney, Camperdown, NSW, 2050, Australia., Jankovic D; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.; Immunoparasitology Unit, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Lamiable O; Malaghan Institute of Medical Research, Wellington, 6012, New Zealand., Mayer-Barber KD; Inflammation and Innate Immunity Unit, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA., Sher A; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA. asher@niaid.nih.gov.

Publikováno v: Nature communications [Nat Commun] 2023 Dec 12; Vol. 14 (1), pp. 8229. Date of Electronic Publication: 2023 Dec 12.

Homeostatic IL-13 in healthy skin directs dendritic cell differentiation to promote T H 2 and inhibit T H 17 cell polarization.

Autor: Mayer JU; Malaghan Institute of Medical Research, Wellington, New Zealand.; Department of Dermatology and Allergology, Phillips University Marburg, Marburg, Germany., Hilligan KL; Malaghan Institute of Medical Research, Wellington, New Zealand.; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Chandler JS; Malaghan Institute of Medical Research, Wellington, New Zealand., Eccles DA; Malaghan Institute of Medical Research, Wellington, New Zealand., Old SI; Malaghan Institute of Medical Research, Wellington, New Zealand., Domingues RG; Lydia Becker Institute of Immunology and Inflammation, Manchester Collaborative Centre for Inflammation Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK., Yang J; Malaghan Institute of Medical Research, Wellington, New Zealand., Webb GR; Malaghan Institute of Medical Research, Wellington, New Zealand., Munoz-Erazo L; Malaghan Institute of Medical Research, Wellington, New Zealand., Hyde EJ; Malaghan Institute of Medical Research, Wellington, New Zealand., Wakelin KA; Malaghan Institute of Medical Research, Wellington, New Zealand., Tang SC; Malaghan Institute of Medical Research, Wellington, New Zealand., Chappell SC; Malaghan Institute of Medical Research, Wellington, New Zealand., von Daake S; Malaghan Institute of Medical Research, Wellington, New Zealand., Brombacher F; International Centre for Genetic Engineering and Biotechnology (ICGEB), Cape Town component & Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology, Health Science Faculty, University of Cape Town, Cape Town, South Africa., Mackay CR; Infection and Immunity Program, Monash Biomedicine Discovery Institute, Monash University, Melbourne, VIC, Australia., Sher A; Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Tussiwand R; Department of Biomedicine, University of Basel, Basel, Switzerland.; Immune Regulation Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA., Connor LM; Malaghan Institute of Medical Research, Wellington, New Zealand.; School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand., Gallego-Ortega D; The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.; Centre for Single-Cell Technology, School of Biomedical Engineering, Faculty of Engineering and IT, University of Technology Sydney, Ultimo, NSW, Australia., Jankovic D; Immunoparasitology Unit, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Le Gros G; Malaghan Institute of Medical Research, Wellington, New Zealand., Hepworth MR; Lydia Becker Institute of Immunology and Inflammation, Manchester Collaborative Centre for Inflammation Research, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK., Lamiable O; Malaghan Institute of Medical Research, Wellington, New Zealand., Ronchese F; Malaghan Institute of Medical Research, Wellington, New Zealand. fronchese@malaghan.org.nz.

Publikováno v: Nature immunology [Nat Immunol] 2021 Dec; Vol. 22 (12), pp. 1538-1550. Date of Electronic Publication: 2021 Nov 18.